Home News & Events Events Webinars Webinars Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Category BiotechCardiovascularCell and Gene TherapiesDigital DisruptionEarly ClinicalInfectious DiseaseInternal Medicine & ImmunologyLaboratoriesMedical ImagingOncologyPediatricsPatient CentricityRare & Orphan DiseasesReal World IntelligenceRegulatory IntelligenceVaccinesValue Based HealthcareWomen's Health Webinars FDA Waivers for TQT Studies Date 8 December 2015 Time 10:00 - 11:00 Location Webinar Timezone America/Lima Previous 1 … 18 19 20 ICON’s Webinar Channel A library of recorded webinars exploring topics ranging from early to late phase. Subscribe Today In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Webpage ICON's Webinar channel Webpage Workshops Webpage Industry events What's happening in ICON ICON Plc Missed our recent webinar from Symphony Health, an ICON plc company? The recording for Riding the data wave: How pharma can navigate disruptions in open claims is now available. Discover how life sciences organisatio... 16 Jan View post View webpage ICON Plc Early phase neurodegenerative trials require careful planning, a patient-first approach, and biomarker strategies that drive progress. Tune in to our recent ASCPT-hosted webinar, where we explored: - How to define target... 18 Dec View post View webpage ICON Plc USP compounding may be fast — but is it costing you quality, compliance, and insight? In this insightful session, our experts discussed: - Why GMP manufacturing offers a strategic edge in early phase trials - Real-worl... 17 Dec View post View webpage ICON Plc In today’s data-rich healthcare landscape, open claims datasets offer unmatched breadth and timeliness. But disruptions—whether from new sources or supplier exits—are inevitable. Join Symphony Health, an ICON plc compan... 3 Dec View post View webpage ICON Plc Open claims datasets are a goldmine for life sciences—but they come with inevitable disruptions. Whether it’s new data sources or supplier exits, knowing how to manage change is key to maintaining strategic advantage. J... 3 Dec 1 View post View webpage ICON Plc Don’t miss out on strategies that could transform your site engagement approach. On 3 December at 10am ET, global experts will share evidence-based methods to ease site burden, accelerate activation, and boost enrolment.... 1 Dec View post View webpage ICON Plc ICH GCP E6(R3) is here. Are you ready to lead the change? The global clinical research landscape is evolving and ICON is at the forefront. Join our upcoming Xtalks webinar to explore the impact, assess the risk and defi... 24 Nov View post View webpage ICON Plc 70% of clinical research sites report a rise in study execution burden. Yet, when investigators enjoy a superior sponsor experience, they may enrol twice as many patients. Join our live webinar on 3 December at 10am ET ... 17 Nov 1 View post View webpage
